Do you...
...know how to get your product to market faster, with reduced development costs and less risk?
...have the experienced resources to be successful?
...have a proven track record of success with the health authorities?
Our goal at CSSi LifeSciences™ is to ensure a successful and expeditious pathway to commercialization for our clients’ development compounds and devices. We do this by providing insight driven analysis that saves time, development costs and resources. More importantly, we enable faster, more informed decision making to increase commercial success, while reducing the risk for late-stage failures and post-authorization action.

CSSi LifeSciences™ has successfully enabled the development of drugs, biologics, devices and in-vitro diagnostics for its clients. Our unique service, positions us to engage with our clients to provide a comprehensive suite of scalable services to develop therapeutic candidates with cost efficient predictability. We have the expertise to support lifecycle strategies to drive product value, extend market share, and maximize the ROI.

Unparalleled Success from Discovery to Commercialization
  • Played a key role in developing over 400 drugs, biologics, compounds, medical devices and in-vitro diagnostics.
  • We have supported 50+ FDA Advisory Panel meetings with 96% success rate
  • Successfully filed over 150 510(K) applications
  • Reduced clients time to approval by 10-15%
  • Our Smart StudyTM designs and feasibility assessments enhance study efficiency and success
Contact us to discuss our capabilities and how we can apply our services to meet your needs.